Paul Howard is a senior fellow and the Director of the Manhattan Institute's Center for Medical Progress. He is the managing editor of Medical Progress Today, a web magazine devoted to chronicling the connection between private sector investment and biomedical innovation, market-friendly public policies, and improved health. As editor, he has written on a wide variety of medical policy issues, including medical malpractice, FDA reform, and Medicare policy initiatives. He is often quoted on health care issues and his columns have appeared in newspapers across the country, including the New York Post, Dallas Morning News, Investor's Business Daily and WashingtonPost.com. He is also a member of the Manhattan Institute's Project FDA, a committee of physician-scientists, economists, medical ethicists, and policy experts. Their purpose is to show how 21st-century technologies can help better inform FDA regulations and accelerate the drug-development and drug-approval process while maintaining drug safety. When Paul first joined the Manhattan Institute in 2000, he worked as the Deputy Director for the Center for Legal Policy where he edited research papers, managed legal policy analyses and organized conferences.
CONTRIBUTORSJosh Bloom is the director of chemical and pharmaceutical sciences at the American Council on Health and Science. He previously worked as a research chemist for Wyeth (Pfizer) for over two decades. At Wyeth he worked in a number of disease areas, including diabetes and obesity, oncology and virology. He received his Ph.D. degree in organic chemistry at the University of Virginia, and also conducted post-doctoral research University of Pennsylvania. He is a native of New York City.
Gregory Conko is a senior fellow at the Competitive Enterprise Institute, a Washington, D.C.-based think tank that studies the intersection of markets, technology, and regulation. His research focuses on food and drug regulation, science and environmental policy, and the general treatment of health risks in public policy. His writings on pharmaceuticals, medical devices, and biotechnology have appeared in scholarly journals including Nature Biotechnology, Transgenic Research, Politics and the Life Sciences, and Health Matrix: The Journal of Law & Medicine, and in such newspapers as The Wall Street Journal, Financial Times, Los Angeles Times, and the San Francisco Chronicle. Mr. Conko's book, The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution, co-authored with Henry I. Miller, was named by Barron's as one of the 25 best books of 2004. And in 2006, he was named by the journal Nature Biotechnology to its short list of "Who's Who in Biotechnology." Mr. Conko earned a B.A. in political science and history from the American University and a J.D. from the George Mason University School of Law, where he served as articles editor of the Journal of Law, Economics & Policy.
Yevgeniy Feyman is a Research Associate with the Manhattan Institute for Policy Research, focusing on a wide range of policy analysis covering healthcare, energy, education, and social policy. He received his B.A. in Economics and Political Science from Hunter College.
Diana Furchtgott-Roth is a senior fellow at the Manhattan Institute and a contributing editor of RealClearMarkets.com. She is also a columnist for The Examiner and a monthly columnist for Tax Notes. Furchtgott-Roth was previously a senior fellow at the Hudson Institute, where she directed the Center for Employment Policy. Her areas of expertise include employment, taxation, education, pensions, unionization, and immigration. From 2003 to 2005, Furchtgott-Roth was chief economist of the U.S. Department of Labor. From 2001 to 2002 she served as chief of staff at the President's Council of Economic Advisers. Furchtgott-Roth served as deputy executive director of the Domestic Policy Council and associate director of the Office of Policy Planning in the White House under President George H.W. Bush from 1991 to 1993, and she was an economist on the staff of President Reagan's Council of Economic Advisers from 1986 to 1987. Furchtgott-Roth is the author of How Obama's Gender Policies Undermine America (Encounter Books 2010) and the editor of Overcoming Barriers to Entrepreneurship in the United States (Rowman and Littlefield, 2008). She is the coauthor of The Feminist Dilemma: When Success Is Not Enough (AEI Press 2001) and Women's Figures: An Illustrated Guide to the Economics of Women in America (AEI Press 1999). Her articles have been published in the Washington Post, Financial Times, The Wall Street Journal, Investor's Business Daily, the Los Angeles Times, and Le Figaro, among others. Furchtgott-Roth is a frequent guest on CNBC and the FOX Business Network, and she has appeared on numerous other TV and radio shows, including The Diane Rehm Show, C-SPAN's Washington Journal and PBS NewsHour with Jim Lehrer. Furchtgott-Roth was assistant to the president and resident fellow at the American Enterprise Institute from 1993 to 2001. From 1987 to 1991 she was an economist at the American Petroleum Institute, where she authored papers on energy and taxation. Furchtgott-Roth received her B.A. in economics from Swarthmore College and her M.Phil. in economics from Oxford University.
David R. Henderson is a research fellow with the Hoover Institution and an associate professor of economics at the Naval Postgraduate School in Monterey, California. He earned his Ph.D. in economics from UCLA. From 1982 to 1984, he was the senior economist for health policy with President Reagan's Council of Economic Advisers. Henderson is the editor of The Concise Encyclopedia of Economics (Liberty Fund, 2008), now on the web at http://www.econlib.org/library/CEE.html and the author of The Joy of Freedom: An Economist's Odyssey. He also blogs at Econlog. He has testified before various U.S. Congressional Committees and before the Food and Drug Administration. He has also appeared on C-SPAN, CNN, the Jim Lehrer Newshour, the O'Reilly Factor, and the Stossel show, and has done radio interviews with NPR, CBC, BBC, and many regional radio stations. He has written for the New York Times, Barron's, Fortune, Los Angeles Times, Chicago Tribune, Public Interest, National Review, and Reason.
Charles L. Hooper is president and co-founder of Objective Insights, Inc., a health care consulting company, and a visiting fellow with the Hoover Institution at Stanford University. Objective Insights is a firm dedicated to providing health care companies with the marketing and financial analysis they need to make informed decisions about their business opportunities. Since its founding in 1994, Objective Insights has completed about 300 projects for 50 clients in the pharmaceutical, biotechnology, diagnostic, and device fields. Clients range from startups to the largest companies. Prior to Objective Insights, Charles worked at NASA/Ames Research Center, Merck & Co., and Syntex Labs (acquired by Roche). He coauthored Making Great Decisions in Business and Life, (Chicago Park Press, 2006). His articles have appeared in The Wall Street Journal, Forbes, The Washington Times, Library of Economics and Liberty, Medical Progress Today, The Concise Encyclopedia of Economics, Hoover Defining Ideas, Reason, The Future of Freedom Foundation, and Tech Central Station. He earned a B.S. in computer science engineering from Santa Clara University and an M.S. in engineering economic systems (since merged into Management Science and Engineering) from Stanford University.
Rita E. Numerof president of Numerof & Associates, Inc. is an internationally acclaimed consultant, author and speaker. She's been a pioneer in the area of economic and clinical value, anticipating the impact of changing global payer attitudes on the fundamental business model of the healthcare industry. Her work across the entire healthcare spectrum -- globally -- gives her a unique perspective on the challenges and needs of suppliers, physicians, payers, and healthcare delivery institutions. Dr. Numerof serves as an advisor to members of Congress on healthcare reform and comparative effectiveness research and has written for the Heritage Foundation on accountable care organizations. She's also an advisor with the Center for Health Transformation and led a tri-partisan, cross-industry work group on payment reform that developed recommendations for new payment models that incent better health outcomes at lower cost. Dr. Numerof is widely published in business journals, and has authored four books, including Solving the Health Care Crisis. She's written extensively on the subject of economic and clinical value creation, health policy and the emerging role of compliance in corporate strategy.
James P. Pinkerton is a contributor to the Fox News Channel and a regular panelist on the Fox "News Watch" show, the highest-rated media-critique show on television. In addition, he writes regularly for Fox News. He is also the editor of SeriousMedicineStrategy.org. In addition, he is a contributing editor to The American Conservative, and an adviser to the BMW Stiftung Herbert Quandt, the foundation of BMW. From 1993 to 2007, he was a twice-a-week columnist for Newsday. He has written for publications ranging from The Wall Street Journal, The New York Times, The Washington Post, The Financial Times, The Los Angeles Times, USA Today, National Review, The New Republic, Foreign Affairs, Fortune, The Huffington Post, US News & World Report, The Washington Examiner, The Guardian, and The Jerusalem Post. He worked in the White House domestic policy offices of Presidents Ronald Reagan and George H.W. Bush and in the 1980, 1984, 1988 and 1992 presidential campaigns. During the 2008 presidential campaign, he served as a senior adviser to the Mike Huckabee for President Campaign.
Avik Roy is a senior fellow at the Manhattan Institute. His research interests include Medicare, Medicaid, and consumer-driven health care. He is author of "The Apothecary," the influential Forbes blog on health care policy and entitlement reform. He writes regularly for Forbes and National Review, and his work has also appeared in National Affairs, USA Today, The American Spectator, and other publications. Roy also works as a health care analyst at Monness, Crespi, Hardt & Co., an investment firm in New York. Previously, he served as an analyst and portfolio manager at J.P. Morgan, Bain Capital, and other firms. He was educated at the Massachusetts Institute of Technology, where he studied molecular biology, and the Yale University School of Medicine.
Alex Tabarrok is Bartley J. Madden Chair in Economics at the Mercatus Center at George Mason University and director of research for The Independent Institute. Tabarrok is co-author with Tyler Cowen of the popular economics blog Marginal Revolution. His recent research looks at the effectiveness of bounty hunters compared to the police, how judicial elections bias judges and how local poverty rates impact trial decisions by juries. Other research examines patent system reform, methods to increase the supply of human organs for transplant and the regulation of pharmaceuticals. He is the author of Modern Principles: Microeconomics and Modern Principles: Macroeconomics (both with Tyler Cowen) and editor of the books Entrepreneurial Economics: Bright Ideas from the Dismal Science, The Voluntary City: Choice, Community, and Civil Society and Changing the Guard: Private Prisons and the Control of Crime. His papers have appeared in the Journal of Law and Economics, Public Choice, Economic Inquiry, Journal of Health Economics, Journal of Theoretical Politics, The American Law and Economics Review, Kyklos and many other journals. Popular articles by Professor Tabarrok have appeared in The New York Times, The Wall Street Journal and many other magazines and newspapers.
Colleen Chambers is an MPT intern.